Every Publication has a Story

At GHPi, we are passionate about research and publishing. Every publication has its own story to tell, including how it was conceptualized and how it has had an impact. See below pieces co-authored by GHPi Director Tim Mackey by year of publication. Click the "learn more" button to hear their stories (still under construction.)

Number of Publications

129

(2008-2018)

Number of Unique Journals

100

*Denotes different journals published in

2018

Topics covered: global governance; substance abuse; health policy; social media

  • Number of Publications:
  • Total Impact Factor:
Original Research
Review
Book Review
Article
Commentary
Author Reply
Correspondence
Commentary

Background: Effective supply chain management is a challenge in every sector, but in healthcare there is added complexity and risk as a compromised supply chain in healthcare can directly impact patient safety and health outcomes. One potential solution for improving security, integrity, data provenance, and functionality of the health supply chain is blockchain technology.

Objectives: Provide an overview of the opportunities and challenges associated with blockchain adoption and deployment for the health supply chain, with a focus on the pharmaceutical supply, medical device and supplies, Internet of Healthy Things (IoHT), and public health sectors.

Methods: A narrative review was conducted of the academic literature, grey literature, and industry publications, in addition to identifying and characterizing select stakeholders engaged in exploring blockchain solutions for the health supply chain.

Results: Critical challenges in protecting the integrity of the health supply chain appear well suited for adoption of blockchain technology. Use cases are emerging, including using blockchain to combat counterfeit medicines, securing medical devices, optimizing functionality of IoHT, and improving the public health supply chain. Despite these clear opportunities, most blockchain initiatives remain in proof-of-concept or pilot phase.

Conclusion: Blockchain technology has the unrealized promise to help improve the health supply chain, but further study, evaluation and alignment with policy mechanisms is needed.


Commentary

The withdrawal of the UK from the European Union (EU) is a complicated event. Although implications vary by industry, the biotechnology sector is especially vulnerable to the consequences of Brexit. Accordingly, here we evaluate potential repercussions under four post-Brexit political pathways: European Economic Area (EEA) affiliation (Norwegian Model); negotiated bilateral access (Swiss Model); limited participation in EU Customs Union (Turkish Model); or independence under the World Trade Organization (WTO) designation. We conclude that all four pathways fail to protect the mutually beneficial UK–EU biotechnology relationship and that alternative pathways need to be explored. Accordingly, we outline a suite of policy mechanisms aimed at ensuring continued EU–UK regulatory synergy, with the central aim of ensuring access to biomedical innovations and ensuring patient safety.


Commentary
Cratsley K, Mackey TK. Global Mental Health and the United Nations’ Sustainable Development Goals. Families, Systems, and Health. 2018;in press.

INTRODUCTION:
Increased awareness of the importance of mental health for global health has led to a number of new initiatives, including influential policy instruments issued by the World Health Organization (WHO) and the United Nations (UN).

METHOD:
This policy brief describes two WHO instruments, the Mental Health Action Plan for 2013-2020 (World Health Organization, 2013) and the Mental Health Atlas (World Health Organization, 2015), and presents a comparative analysis with the Sustainable Development Goals (SDGs) of the UN's 2030 Agenda for Sustainable Development (United Nations, 2015).

RESULTS:
The WHO's Action Plan calls for several specific objectives and targets, with a focus on improving global mental health governance and service coverage. In contrast, the UN's Sustainable Development Goals include only one goal specific to mental health, with a single indicator tracking suicide mortality rates.

DISCUSSION:
The discrepancy between the WHO and UN frameworks suggests a need for increased policy coherence. Improved global health governance can provide the basis for ensuring and accelerating progress in global mental health. (PsycINFO Database Record


Article

Background

Global health diplomacy (GHD) is a burgeoning field bridging the priorities of global health and foreign affairs. Given the increasing need to mobilize disparate global health stakeholders coupled with the need to design complex public health partnerships to tackle issues of international concern, effective and timely cooperation among state actors is critical. Health Attachés represent this coordination focal point and are key diplomatic professionals at the forefront of GHD. Despite their unique mandate, little is published about this profession and the perspectives of those who work in the field.

Methods

Through purposive sampling, we performed in-depth qualitative interviews with seven Health Attachés: three foreign Health Attachés accredited to the United States and four U.S. Health Attachés accredited to foreign governments. Our interviews explored four key topics: the role and mission of Health Attachés, skills needed to perform GHD, examples of successes and challenges in accomplishing their respective missions, and suggestions for the future development of the diplomatic profession.

Results

We identified several lessons to apply to the growing field of GHD. First, GHD actors need to receive appropriate training to successfully negotiate the intersection of global health and foreign affairs. Participants suggested several areas of training that would benefit GHD actors: diplomacy and negotiation, applied science, and cross-cultural competency. Second, participants articulated the need for a career path for GHD practitioners, increased opportunities for on-the-job training and mentored experiences, and GHD competencies with defined levels of mastery that can be used in occupational evaluation and career development.

Conclusions

Our findings indicate that skills in diplomacy and negotiation, applied science, and cross cultural competency are essential for the statecraft of Health Attachés. Additionally, establishing a clear career pathway for Health Attachés is critical for future maturation of the profession and for fostering effective global health action that aligns public health and foreign diplomacy outcomes. Achieving these goals would ensure that this special cadre of diplomats could effectively practice GHD and would also better position Health Attachés to take the lead in advancing shared global health goals among nation states in a new era of twenty-first century diplomacy.

Electronic supplementary material

The online version of this article (10.1186/s12992-017-0316-7) contains supplementary material, which is available to authorized users.



2017

Topics covered: heath and human rights; global governance; substance abuse; health policy; social media

  • Number of Publications:
  • Total Impact Factor:
Original Research
Review
Book Review
Article
Commentary
Author Reply
Correspondence
Original Research
Kalyanam J, Mackey T. Detection and Characterization of Illegal Marketing and Promotion of Prescription Drug Abuse on Twitter. NIPS 2017 Workshop on Machine Learning for Health (ML4H). 2017; https://arxiv.org/abs/1712.00507.

Review
Guerra C, Mackey TK. Am J. Public Health. Criminal and Civil Prosecutions Associated with Illicit Online Pharmacies: Legal Analysis and Global Implications. Medicines Access @ Point of Care. 2017;1(1):e104-e118.OAlogosmall

Original Research
Mackey TK, Kalyanam J, Katsuki T, Lanckriet G. Twitter-Based Detection of Illegal Online Sale of Prescription Opioid. Am J. Public Health. 2017; 107:1910-1915.

Book Review
Mackey TK. Who Governs Global Health? International Politics Reviews. 2017; in press.

Review
Kalyanam J, Mackey TK. A Review of Digital Surveillance Methods and Approaches to Combat Prescription Drug Abuse. Current Addiction Rep. 2017; in press.

Original Research
Cuomo RE, Seidman RL, Mackey TK. Country and Regional Variation in Purchase Prices for Essential Cancer Medications. BMC Cancer. 2017;17:566.OAlogosmall

Commentary
Mackey TK, Kohler JC, Lewis M, Vian T. Combating Corruption in Global Health. Science Transl Med. 2017;9(402):eaaf9547.

Correspondence
Annaloro J, Mackey TK. Policy Implications for post-Brexit Biotech. Nature Biotechnol. 2017;35:710-711.

Original Research
Tringale K, Marshall D, Mackey TK, Connor M, Murphy J, Hattangadi-Gluth J. Types and Distribution of Payments from Industry to Physicians in 2015. JAMA. 2017;317(17):1774-1784.

Review
Mackey TK, Nayyar G. A Review of Existing and Emerging Digital Technology to Combat the Global Fake Medicines Trade. Expert Opinion Drug Safety. 2017; advanced online publication

Original Research

Author Reply
Mackey TK, Liang BA. In Reply - EHR and Drugs Prescribed for Off-label Indications. Mayo Clin Proc. 2017; 92(4):684-685.

Article
Akbarzada S, Mackey TK. The Syrian Public Health and Humanitarian Crisis: A “Displacement” in Global Governance? Glob Public Health. 2017; advanced online publication

Original Research

Article

2016

Topics covered: tobacco control; health migration; international trade; biotechnology; digital health; social media; health policy; health communication; online pharmacies; drug access; pharmaceutical policy; global health governance; infectious diseases; health emergencies; patient safety; health diplomacy; pharmaceutical marketing; substance abuse; corruption; environmental health; health diplomacy; genetics;

  • Number of Publications: 19
  • Total Impact Factor:
Original Research
Review
Article
Short Report
Commentary
Perspective
Debate
Policy Forum
Editorial
Professional Review
Forum
Perspective
Aleeban M, Mackey TK. Global Health Policy and Visa Reform to Address Dangers of Hajj During Summer Seasons. Front. Public Health. 2016; 4:280 OAlogosmall

Debate
Mackey TK. The Ebola Outbreak: Catalyzing a “Shift” in Global Health Governance? BMC Infect Dis. 2016;16(1):699. OAlogosmall

Forum
Mackey TK, Kohler JC, Savedoff WD, Vogl F, Lewis M, Sale J, Michaud J, Vian T. The disease of corruption: views on how to fight corruption to advance 21st century global health goals. BMC Med. 2016;14(1):149. OAlogosmall

Original Research
Marshall DC, Moy B, Jackson ME, Mackey TK, Hattangadi-Gluth JA. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014. J. Natl Cancer Inst. 2016; advanced online publication

Article
Brown M, Bergmann J, Mackey T, Eichbaum Q, McDougal L, Novotny T. Mapping Foreign Affairs and Global Public Health Competencies: Towards a Competency Model for Global Health Diplomacy. Global Health Governance. 2016;X(2):3-49 OAlogosmall

Debate
Setayesh S, Mackey TK. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Global Health. 2016;12:31. OAlogosmall


Commentary
Schandera J, Mackey TK. Mitochondrial Replacement Therapy: Divergence in Global Policy. Trends Genet. 2016; 32(7):385-90

Review
Mackey TK, Nayyar G. Digital Danger: A Review of the Global Public Health, Patient Safety and Cybersecurity Threats Posed by Illicit Online Pharmacies. Br Med Bull. 2016; advanced online publication

Professional Review
Foster-Bollman C, Mackey TK. Gadolinium-based Contrast Agents: Patient Safety Concerns. Radiol Technol. 2016;87(5):552-556

Commentary
Mackey TK. Lessons from Liberia: Global Health Governance in the Post-Ebola Paradigm. Global Health Governance. 2016;X(1):60-70.  OAlogosmall


Commentary
Mackey TK, Liang BA. After Amarin: What Will the Future Hold for Off-Label Promotion Regulation? Mayo Clin Proc. 2016; 91(6):701-706

Policy Forum
Alsaraf M, Mackey TK. Child-Resistant Packaging for Liquid Nicotine: Are Current State and Federal Policy Responses Adequate? Food and Drug Law Institute Policy Forum. 2016;6(2):1-13


Editorial
Attaran A, Mackey TK, Reed, B. Lowering the High Cost of Cancer Drugs - III. Mayo Clin Proc. 2016;91(3):399-400

Article
Anderson A, Mackey TK, Attaran A, Liang BA. Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies. J. Health Commun. 2016;21(4):397-407

Article
Mackey TK, Schoenfeld V. Going "Social" to Access Experimental and Potentially Life-Saving Treatment: An Assessment of the Policy and Online Patient Advocacy Environment for Expanded Access. BMC Medicine. 2016; 14:17. OAlogosmall


Commentary
Mackey TK. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”. Int J Health Policy Manag. 2016;5(4):271-274 OAlogosmall

Article
Azar S, Mackey TK. Crowdfunding: A New Untapped Opportunity for Biotechnology Start-ups? Journal of Commercial Biotechnology: 2016; 21(4):15-28

Article
Efendi F, Mackey TK, Huang MC, Chen CM. IJEPA – A Gray Area in Health Policy and Trade for Indonesian Nurse Migration. Nurs Ethics: 2016; advanced online publication

Short Report
Cuomo RE, Miner A, Mackey TK. Pricing and Sales Tax Collection Policies for E-Cigarette Starter Kits and Disposable Products Sold Online. Drug Alcohol Rev: 2016; advanced online publication

2015

Topics covered: drug safety, social media, tobacco control, pharmaceutical policy; pharmaceutical marketing; digital health; fake medicines; substance abuse; indigenous health; health policy; health diplomacy; healthcare ethics

  • Number of Publications: 13
  • Total Impact Factor:
Original Research
Article
Commentary
Review
Perspective
Article
Lincoln E, Liang BA, Mackey TK. Interculturalidad and Chilean Health: Stakeholders Perceptions and the Intercultural Hospital Delivery Model. International Journal of Indigenous Health: 2015; 10(2): 66-87

Original Research
Katsuki T, Mackey TK., Cuomo RE. Establishing a Link Between Prescription Drug Abuse and Illicit Online Pharmacies: Analysis of Twitter Data. Journal of Medical Internet Research: 2015; 17(12): e280 OAlogosmall

Review

Original Research
Mackey TK, Miner A, Cuomo RE. Exploring the e-Cigarette e-Commerce Marketplace: Identifying Internet e-Cigarette Marketing Characteristics and Regulatory Gaps. Drug Alcohol Depend: 2015; 156:97-103

Original Research
Mackey TK, Aung P, Liang BA. Illicit Internet availability of drugs subject to recall and patient safety consequences. Int’l J. Clinc Pharm: 2015; 37(6):1076-1085

Original Research
Mackey TK, Cuomo RE, Liang BA. The Rise of Digital Direct-to-Consumer Advertising?: Comparison of Direct-to-Consumer Advertising Expenditure Trends from Publicly Available Data Sources and Global Policy Implications. BMC Health Serv Res: 2015; 15:236


Article
Solomonides AE, Mackey TK. Emerging Ethical Issues in Digital Health Information: ICANN, Health Information and the “dot health” top level domain. Camb Q Healthc Ethics: 2015; 24(3):311-22

Original Research
Cuomo RE, Mackey TK, Stigler P. The Economics of Counterfeit Avastin: A Geospatial and Statistical Analysis of Demographic Correlates to FDA Warning Letters. Pharmacoepidemiol Drug Saf: 2015; 24(7):748-756

Original Research
Mackey TK, Liang BA, York P, Kubic T. Counterfeit Drug Penetration into Global Legitimate Supply Chains: A Global Assessment. Am J. Trop. Med. Hygiene: 2015; 92(6):59-67

Commentary
Mackey TK, Strathdee SA. Responding to the Public Health Consequences of the Ukraine Crisis: An Opportunity for Global Health Diplomacy. J Int AIDS Soc: 2015;18:19410  OAlogosmall


Perspective
Mackey TK, Cuomo RE, Guerra C, Liang BA. After Counterfeit Avastin – What Have We Learned and What can be Done? Nat Rev Clin Oncol: 2015; 12:302-308

Commentary
Mackey TK, Strathdee SA. Big Events and Risks to Global Substance Using Populations: Unique Threats and Common Challenges. Substance Use & Misuse: 2015; 50(7): 885-890


Commentary
Mackey TK, Liang BA. It’s Time to Shine the Light on Direct-to-Consumer Advertising. Ann Fam Med.: 2015; 13(1):82-85

2014

Topics covered: fake medicines; drug safety; patient safety; substance abuse; global health governance; infectious diseases; innovation; public health and IP; digital health; tobacco control; biologics; drug access; pharmaceutical marketing; health migration; international trade; dental policy; environmental health; health policy; health diplomacy

  • Number of Publications: 14
  • Total Impact Factor:
Original Research
Review
Article
Commentary
Debate
Policy Forum
Editorial
Law Review
Original Research
Cuomo RE, Mackey TK. An Exploration of Counterfeit Medicine Surveillance Strategies Guided by Geospatial Analysis: Lessons Learned from Counterfeit Avastin Detection in the U.S. Drug Supply Chain. BMJ Open: 2014; 4:e006657 OAlogosmall

Commentary
Mackey TK, Liang BA. Digital Iatrogenesis: Policy Advocacy to Prevent Patient Harm from Access to Dangerous Drugs Online. Harvard Health Policy Review: 2014; 14(1): 11-13 OAlogosmall

Commentary
Mackey TK, Werb D, Beletsky L, Rangel G, Arredondo J, Strathdee SA. Mexico’s “ley de narcomenudeo” Drug Policy Reform and the International Drug Control Regime. Harm Reduction Journal: 2014; 11:31 OAlogosmall

Review
Mackey TK, Liang BA, Cuomo R, Hafen R, Brouwer KC, Lee DE. Emerging and Reemerging Neglected Tropical Diseases: A Review of Key Characteristics, Risk Factors, and the Policy and Innovation Environment. Clin. Microbiol. Rev. 2014; 27(4):949

Article
Brown M, Mackey TK, Shapiro CN, Kolker J, Novotny TE. Bridging Public Health and Foreign Affairs: The Tradecraft of Global Health Diplomacy and the Role of Health Attachés. Science & Diplomacy: 2014; 3(3) OAlogosmall

Commentary
Mackey TK, Eysenbach G, Liang BA, Kohler JC, Geissbuhler A, Attaran A. A Call for a Moratorium on the .health Generic Top-Level Domain: Preventing the Commercialization and Exclusive Control of Online Health Information. Global Health: 2014; 10:62 OAlogosmall


Editorial
Werb D, Medina Mora ME, Beletsky L, Rafful C, Mackey T, Arrendondo J, Strathdee S. Mexico’s Drug Policy Reform: Cutting Edge Success or Crisis in the Making? Int’l J. Drug Policy: 2014; 25:823-825

Policy Forum
Mackey TK, Liang BA, Pierce JP, Bostic C, Laurent H. Call to Action: Promoting Domestic and Global Tobacco Control by Ratifying the Framework Convention on Tobacco Control in the United States. PLoS Med. 2014;11(5): e1001639 OAlogosmall

Commentary
Mackey TK, Liang BA, Kohler JC, Attaran A. Health Domains for Sale: The Need for Global Health Internet Governance. J Med Internet Res. 2014;16(3):e62 OAlogosmall

Debate
Kohler JC, Mackey TK, Ovtcharenko N. Why the MDGs need Good Governance in Pharmaceutical Systems to Promote Global Health. BMC Public Health. 2014;14(63)  OAlogosmall


Law Review
Liang BA, Mackey TK. Public-Private Partnerships to Promote Biosimilar Access, Affordability, and Patient Safety in Emerging Markets. Stanford J Law Sci Policy: 2014; 7(1):1-9

Commentary
Mackey TK, Yagi N, Liang BA. Prescription Drug Coupons: Evolution and Need for Regulation in Direct-to-Consumer Advertising. Res Social Admin Pharm.; 2014; 10(3):588-594


Review
Yagi N, Mackey TK, Gerlt L, Liang BA. Policy Review: Japan-Philippines Economic Partnership Agreement (JPEPA)—Analysis of a Failed Nurse Migration Policy. Inter J Nurs.; 2014; 51:243-250

Commentary
Mackey TK, Contreras JT, Liang BA. The Minamata Convention on Mercury: Attempting to Address the Global Controversy of Dental Amalgam Use and Mercury Waste Disposal. Sci Tot Env. 2014;472:125-129


2013

Topics covered: fake medicines; pharmaceutical marketing; digital health; conflicts of interest; stem cells; substance abuse; social media; reproductive health; online pharmacies; pharmaceutical policy; elder abuse; global health governance; tobacco control; health policy; health migration

  • Number of Publications: 17
  • Total Impact Factor:
Original Research
Article
Review
Commentary
Debate
Law Review
Correspondence
Author Reply
Debate
Mackey TK, Liang BA. Improving Global Health Governance to Combat Counterfeit Medicines: A Proposal for a UNODC-WHO-Interpol Trilateral Mechanism. BMC Medicine. 2013;11:233 OAlogosmall

Debate
Mackey TK, Liang BA. Pharmaceutical Digital Marketing and Governance: Illicit Actors and Challenges to Global Patient Safety and Public Health. Glob Health. 2013; 9(1):45 OAlogosmall

Correspondence
Mackey TK, Liang BA, Kohler J, Attaran A. The Fight over dot-health: Ensuring the Future of Health Information Online. The Lancet. 2013; 382:1404 OAlogosmall

Article
Liang BA, Mackey TK, Lovett KM. Technology and Medicine: Academic Dishonesty and Risks to Global Health. J Comm Biotech. 2013;19(4):42-48

Review
Mackey TK. Global Health Diplomacy and the Governance of Counterfeit Medicines: A Mapping Exercise of Institutional Approaches. J Health Diplomacy. 2013;1(1)

Article
Mackey TK, Liang BA. Dangerous Science: Online Promotion of Unproven Stem Cell Therapies and Global Health Risks. J Comm Biotech. 2013;19(4):19-28


Commentary
Mackey TK, Liang BA, Strathdee SA. Digital Social Media, Youth and Non-Medical Use of Prescription Drugs: The Need for Reform. J Med Internet Res. 2013; 15(7):e143 OAlogosmall

Author Reply
Liang BA, Mackey TK, Lovett KM. Reply to Stanback et al. “Suspect Online Sellers and Contraceptive Access”? Contraception. 2013;88(4):583

Commentary
Liang BA, Mackey TK, Archer-Hayes A, Shinn L. Illicit Online Marketing of Lorcaserin Before DEA Scheduling. Obesity. 2013;21(5):861-864

Original Research
Mackey TK, Liang BA. Global Reach of Direct-to-Consumer Advertising Using Social Media for Illicit Online Drug Sales. J Med Internet Res. 2013;15(5):e105  OAlogosmall


Original Research
Liang BA, Mackey TK, Lovett KM. Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs. Clin Ther. 2013;35(5):694-700

Law Review
Lovett KM, Mackey TK. Online Threats to Senior Safety: The Direct-to-Consumer Medical Marketplace and eElder Abuse. Nat Acad Elder Law Attorneys J. 2013;9(1):91-113


Commentary
Mackey TK, Liang BA, Novotny T. Evolution of Tobacco Labeling and Packaging: Global Health Governance and International Legal Considerations. Am J Pub Health. 2013;103(4):e39-e43

Commentary
Mackey TK, Liang BA. Physician Payment Disclosure Under Healthcare Reform: Will the Sun Shine? J Am Board Fam Med. 2013;26: 327-331.

Article
Mackey TK, Liang BA. Restructuring Brain Drain: Governance and Financing Strengthening for Health Worker Migration. Glob Health Action. 2013;6:19923 OAlogosmall


Author Reply
Mackey TK, Liang BA. A Response to Commentaries on “A United Nations Global Health Panel for Global Health Governance.” Soc Sci Med. 2013;76(1):24-27

Commentary
Mackey TK, Liang BA. A United Nations Global Health Panel for Global Health Governance. Soc Sci Med. 2013;76(1):12-15

2012

Topics covered: global health governance; pharmaceutical policy; online pharmacies; corruption; pharmaceutical promotion; drug access; infectious diseases; reproductive health; health migration; health security; biologics; medical screening; fake medicines; stem cells; sleep health; elder abuse; health economics; health diplomacy

  • Number of Publications: 29
  • Total Impact Factor:
Original Research
Review
Article
Commentary
Perspective
Debate
Short Report
Editorial
Correspondence
Article
Mackey TK, Novotny TE. Improving United Nations Funding to Strengthen Global Health Governance: Amending the Helms-Biden Agreement. Global Health Governance. 2012;6(1) OAlogosmall

Commentary
Mackey TK, Liang BA. Oncology and the Internet: Regulatory Failure and Reform. J Onc Prac. 2012;8(6);341-343

Debate
Mackey TK, Liang BA. Combating Healthcare Corruption and Fraud with Improved Global Health Governance. BMC Intl Health Hum Rights. 2012;12:23 OAlogosmall

Commentary
Lovett KM, Liang BA, Mackey TK. Online Direct-to-Consumer Access to Insulin: Patient Safety Considerations and Reform. J Diab Sci Tech. 2012;6(6):1503-1506

Original Research
Mackey TK, Liang BA. Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease. PLoS One. 2012;7(11):e51022 OAlogosmall

Review
Mackey TK, Liang BA. Threats from Emerging and Re-emerging Neglected Tropical Diseases. Infec Ecol Epi. 2012;2(1):18667 OAlogosmall


Commentary
Mackey TK, Liang BA. Promoting Global Health: Utilizing WHO to Integrate Public Health, Innovation and Intellectual Property. Drug Disc Today. 2012;17(24-25):1254-1257

Original Research
Liang BA, Mackey TK, Lovett KM. Suspect Online Sellers and Contraceptive Access. Contraception. 2012;86(5):551-556

Article
Liang BA, Mackey TK, Lovett KM. Emerging Dangers from Direct Botulinum Access and Use. J Homeland Sec Emerg Manag. 2012;9(1):art.9

Article
Mackey TK, Liang BA. Brain Drain: Exploring Resource Allocation to Address Health Worker Migration and Promote Global Health. Health Policy. 2012;107(1):66-73


Original Research
Lovett KM, Mackey TK, Liang BA. Evaluating the evidence: direct-to-consumer screening tests advertised online. J Med Screen. 2012;19:141–153

Article
Liang BA, Mackey TK. Tipping Point: Biosimilars, Emerging Markets, and Public-Private Engagement to Promote Global Health. J Comm Biotech. 2012;18(4):65-74


Article
Mackey TK, Liang BA. Globalization, Evolution and Emergence of Direct-to-Consumer Advertising: Are Emerging Markets the Next Pharmaceutical Marketing Frontier? J Comm Biotech. 2012;18(4):58-64

Article
Brown M, Mackey TK, Liang BA. Global Health Diplomacy and Management Mechanisms of US-China Public Health Collaborations in China: Lessons for Emerging Markets. J Comm Biotech. 2012;18(4):44-50

Editorial
Liang BA, Mackey TK. Sexual Medicine: Online Risks to Health-The Problem of Counterfeit Drugs. Nature Rev Urol. 2012;9:480-482 OAlogosmall


Commentary
Liang BA, Mackey TK. Stem Cells, Dot-Com. Sci Trans Med. 2012;4(151):151cm9

Editorial
Mackey TK, Liang BA. Separating Online Piracy from Counterfeit Medicines: The Need for Policy Reform and a Call to Action. Health Policy Tech. 2012;1:120-122

Editorial
Mackey TK, Liang BA. Global Health Policy Coordination to Address Neglected Tropical Diseases. Trop Med Inter Health 2012;17(9):1053-1056

Review
Mackey TK, Liang BA. Transparency in Physician-Industry Relationships: State and Federal Efforts. Path Case Rev. 2012;17(4):144-147

Commentary
Mackey TK, Liang BA. Promoting Access to Biosimilars: A Public-Private Partnership Model for Biosimlar Development in Underserved Populations. GaBI J. 2012;1(2):84-88

Commentary
Mackey TK, Liang BA. Integrating Biodiversity Management and Indigenous Biopiracy Protection to Promote Environmental Justice and Global Health. Am J Pub Health. 2012;102(6):1091-1095

Commentary
Lovett KM, Liang BA, Mackey TK. Risks of Online Direct-to-Consumer Tumor Markers for Cancer Screening. J Clin. Onc. 2012;30(13):1411-1414

Editorial
Liang BA, Mackey TK. Biosimilars and Patient Safety Risk: Promoting Policy Protections in the Health Delivery System. Rev Health Care. 2012;3(2):71-74

Correspondence
Liang, BA, Mackey TK. Creating Illicit Laparoscopic Appendectomy Operating Rooms Using Online Sourcing. Am Surg. 2012;78(4):502-503

Commentary
Mackey TK, Liang BA, Lovett KM. Waking Up to the Risks of Online Direct-to-Consumer Advertising of Sleep Apnea Screening Tests. J Clin Sleep Med. 2012;8(1):5-6

Original Research
Liang BA, Mackey TK. Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics. J Med Internet Res. 2012;14(1):e27

Editorial
Liang BA, Lovett KM, Mackey, TK. Elder Abuse. J Am Geriatr Soc. 2012;60:398–400. doi: 10.1111/j.1532-5415.2011.03798.x

Article
Mackey TK, Liang BA. Lessons from SARS and 2009 H1N1 influenza: Employing a WHO-WTO Forum to Promote Optimal Economic-Public Health Pandemic Response. J Pub Health Policy 2012;33(1):119-131 doi:10.1057/jphp.2011.51 [accompanied by editorial commentary]

Short Report
Liang BA, Mackey TK. Vaccine Shortages and Suspect Online Pharmacy Sellers. Vaccine. 2012;30(2):103-105

2011

Topics covered: health ethics; health policy; biologics; pharmaceutical promotion; pharmaceutical policy; healthcare reform; fake medicines; social media; online pharmacies; medical malpractice

  • Number of Publications: 10
  • Total Impact Factor:
Original Research
Law Review
Commentary
Article
Article
Liang BA, Mackey TK, Lovett, KM. eHealth Ethics: The Online Medical Marketplace and Emerging Ethical Issues. Ethics Biol Eng Med. 2011;2(3):253-265 OAlogosmall

Commentary
Liang BA, Mackey TK. Emerging Patient Safety Issues Under Healthcare Reform: Follow On Biologics and Immunogenicity. Ther Clin Risk Manag. 2011;7:483-489 OAlogosmall

Law Review
Mackey TK, Liang BA. Off Label Promotion Reform: A Legislative Proposal Addressing Vulnerable Patient Drug Access and Limiting Inappropriate Pharmaceutical Marketing. Univ Mich J Law Reform. 2011; 45(1):1-54

Article
Liang BA, Mackey TK. Quality and Safety in Health Care: What Does What the Future Hold? Arch Path Lab Med. 2011;135:1425-1431

Commentary
Mackey TK, Liang BA. The Global Counterfeit Drug Trade: Patient Safety and Public Health Risks. J Pharm Sci. 2011;100(11):4571-4579

Original Research
Liang BA, Mackey TK. Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising. J Med Internet Res. 2011;13(3):e64 OAlogosmall


Article
Mackey TK, Liang BA. Promoting Online Drug Safety: Using Public–Private Partnerships to Deter Illicit Online Drug Sales. J Comm Biotech. 2011;17(3):266-271

Commentary
Liang BA, Mackey TK. Reforming Direct-to-Consumer Advertising. Nature Biotech. 2011; 29(5):397-400

Commentary
Liang, BA, Mackey TK. Direct to Consumer Advertising with Interactive Internet Media: Global Regulation and Public Health Issues. JAMA. 2011; 305(8):824-825

Commentary
Mackey TK, Liang BA. The Role of Practice Guidelines in Medical Malpractice Litigation. AMA Journal of Ethics (formerly Virtual Mentor). 2011;13(1):36-41


2010

Topics covered: conflicts of interest; pharmaceutical policy; rare diseases; health policy

  • Number of Publications: 4
  • Total Impact Factor:
Law Review
Policy Forum
Commentary
Author Reply
Commentary
Liang BA, Mackey TK. Addressing Institutional Conflict of Interest to Promote Patient Safety. Pat Safety Qual Healthcare. 2010;7(6):36-39

Law Review
Liang BA, Mackey TK. Confronting Conflict: Addressing Institutional Conflicts of Interest in Academic Medical Centers. Am J Law Med. 2010;36(1):136-187

Author Reply
Liang BA, Mackey TK. Consent Contraindicated? In Reply. Science.2010;328(5974):45

Policy Forum
Liang BA, Mackey TK. Reforming Off-Label Promotion to Enhance Orphan Disease Treatment. Science. 2010; 327(5963):273-274

2009

Topics covered: online pharmacies; digital health; health policy; environmental policy

  • Number of Publications: 3
  • Total Impact Factor:
Law Review
Commentary
Author Reply
Commentary
Mackey TK, Liang BA. Incentivizing “Green” Technology Transfer to Developing Countries. J Biolaw Bus. 2009;12(4): 11-14

Author Reply
Liang BA, Mackey TK. Searching for Safety: A Reply to Cooperman and Levitt. Am J Law Med. 2009;35(4):687-694

Law Review
Liang BA, Mackey TK. Searching for Safety: Addressing Search Engine, Web site, and Provider Accountability for Illicit Online Drug Sales. Am J Law Med. 2009;35(1):125-184
© 2017 Global Health Policy Institute Contact Us